Oppenheimer
125 Broad Street
New York
New York
10004
United States
Tel: 212-668-8000
354 articles about Oppenheimer
-
Oppenheimer Hires Joel Sendek As Head of Healthcare Life Sciences Research Team, Further Bolstering the Firm's Commitment to an Important Area of Focus
9/15/2022
Oppenheimer & Co. Inc. announced the ongoing expansion of its Healthcare Life Sciences Research Team within the firm's Equity Research Department with the appointment of Joel Sendek as Managing Director and Head of Healthcare Life Sciences Equity Research.
-
Oppenheimer & Co. Inc. Begins 32nd Annual Healthcare Conference, Drawing Over 280 Companies, Nearly 1,200 Participants
3/15/2022
Oppenheimer & Co. Inc., a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings, announced the launch of its 32nd annual Healthcare Conference, to be held virtually through March 17.
-
Oppenheimer Builds Out Healthcare Investment Banking Team To Support Accelerating Growth
3/23/2021
Jonathan Fassberg Named Vice Chairman of Healthcare Investment Banking, Brian Korb Joins as Managing Director and Don Ritucci Appointed Head of M&A for Firm's Healthcare Investment Banking Team
-
Oppenheimer To Host Houston Oncology Summit At The University of Texas MD Anderson Cancer Center
10/10/2019
Oppenheimer & Co. Inc. will host its Houston Oncology Summit on October 17, 2019 at the University of Texas MD Anderson Cancer Center.
-
Investors And Biotech Leaders Gather In New York For Oppenheimer's Oncology Insight Summit
5/15/2019
Oppenheimer & Co. Inc. – a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings – will host its New York Oncology Insight Summit at The Barclay Intercontinental Hotel in New York City on May 16, 2019.
-
From New Treatments To Changing Policies, Industry Leaders Discuss Changing Healthcare Landscape At Oppenheimer & Co. Inc's Annual Conference
3/19/2019
The Marwood Group will present the keynote lunch address on Tuesday, while Wednesday's keynote lunch speaker will be Dr. Jason Luke from the University of Chicago, who will address how to spot red flags in early clinical trials.
-
This year has been a strong one for biotech initial public offerings (IPO). According to the Wall Street Journal, as of mid-October, 55 biotech companies had raised $5.75 billion.
-
Oppenheimer & Co. Inc. Concludes Its Twenty-Eighth Annual Healthcare Conference In New York City
3/22/2018
Oppenheimer & Co. Inc. recently hosted its 28th Annual Healthcare Conference in New York City on March 20 and 21, 2018.
-
Oppenheimer Strengthens Life Sciences Team With New Managing Director
2/26/2018
Oppenheimer & Co. Inc. ("Oppenheimer") - a leading wealth manager and investment bank and a subsidiary of Oppenheimer Holdings (NYSE:OPY) - today announced Leland Gershell, M.D., Ph.D. joined the Firm as Managing Director and Senior Analyst on the Life Sciences research team.
-
Ex-Oppenheimer Adviser Pleads Guilty to U.S. Insider Trading Charges
10/26/2016
-
Omega Protein Corporation To Present At The Oppenheimer 16th Annual Consumer Conference
6/9/2016
-
Oramed To Present At Oppenheimer Annual Israeli Conference
5/16/2016
-
Compugen Ltd. To Present At The Oppenheimer Annual Israeli Conference In Tel Aviv
5/16/2016
-
Only Days After a Follow-On Offering, San Diego's Sophiris Bio Hires Oppenheimer to Explore Strategic Options
5/13/2016
-
Oppenheimer's 26th Annual Healthcare Conference Provides Investors With Access To More Than 140 Public And Private Healthcare Companies
12/10/2015
-
Nektar Therapeutics To Present At Oppenheimer 26th Annual Healthcare Conference In New York
12/9/2015
-
OvaScience To Present At The Oppenheimer Healthcare Conference
12/8/2015
-
ANI Pharma Presents At Oppenheimer 26th Annual Healthcare Conference
12/8/2015
-
Lexicon Pharma To Present At The Oppenheimer 26th Annual Healthcare Conference
12/7/2015
-
The Medicines Company To Participate In Oppenheimer 26th Annual Healthcare Conference
12/4/2015